Vascular targeted therapy with anti-prostate-specific membrane antigen monoclonal antibody J591 in advanced solid tumors. [electronic resource]
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology Feb 2007
- 540-7 p. digital
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
1527-7755
10.1200/JCO.2006.07.8097 doi
Adult Aged Aged, 80 and over Antibodies, Monoclonal--adverse effects Antigens, Neoplasm--immunology Antigens, Surface--immunology Antineoplastic Agents--adverse effects Drug Delivery Systems Endothelium, Vascular--immunology Female Glutamate Carboxypeptidase II--immunology Humans Immunohistochemistry Male Middle Aged Neoplasms--blood supply Neovascularization, Pathologic--diagnostic imaging New York City Radionuclide Imaging Radiopharmaceuticals--pharmacokinetics Time Factors Treatment Outcome